Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Certolizumab pegol
Cimzia
Routinely available
NICE (TA375 (SMC 590/09))
29/03/2023
Indication
Moderate to severe active rheumatoid arthritis in adult patients.
Therapeutic Area
Musculoskeletal and joint diseases
Status Description
Routinely available in line with national guidance
Formulation
200mg/mL solution for injection (prefilled syringe)
Comments
March 23 - ERF Status update included in the pathway Treatment of Rheumatoid Arthritis with biologics in pregnancy.
Link to Advice
Advice Published
26/01/2016